文献速递胸部CT

疫情环境下无症状及症状前早期SARS-CoV-2感染者的CT与临床评估

CT and clinical assessment in asymptomatic and pre-symptomatic patients with early SARS-CoV-2 in outbreak settings.
PubMed 文献 · Eur Radiol · 2020-11-04

回顾性分析74例RT-PCR确诊、就诊时无症状的SARS-CoV-2感染者,48例(65%)胸部CT出现浸润灶,且较症状出现提前3.8天。体温升高、CRP及KL-6与CT浸润灶存在相关,浸润灶体积、肺部受累百分比及实变与后续出现症状相关。

要点

  • 74例无症状感染者中48例(65%)入院当日CT已见浸润灶,较症状出现提前3.8天(范围1-5天)。
  • 最常见CT表现为磨玻璃影(45/48;94%)和实变(22/48;46%)。
  • 体温升高、CRP升高及KL-6升高与CT浸润灶存在相关;浸润灶体积、肺部受累百分比及实变与后续出现症状相关。

核心结论

  • 约三分之二的无症状SARS-CoV-2感染者CT浸润灶先于症状出现;体温升高和实验室检查可能识别就诊时已有CT浸润灶的无症状患者,CT浸润灶特征可能有助于识别后续出现症状的无症状患者。

研究设计与样本

  • 回顾性研究,从日本和中国825例因暴露或旅行风险而行胸部CT且RT-PCR阳性的患者中识别出74例就诊时无症状的RT-PCR确诊SARS-CoV-2感染者;所有患者入院一日内行胸部CT,由深度学习工具辅助评估浸润灶亚型及百分比,采用单因素和多因素logistic回归分析临床、实验室与影像特征的相关性。

关键影像表现/征象

  • 48/74(65%)初始无症状患者CT可见浸润灶,且较症状出现提前3.8天(范围1-5天)。
  • 最常见的CT浸润灶为磨玻璃影(45/48;94%)和实变(22/48;46%)。

诊断标准与关键数值

  • 体温(p < 0.01)、CRP(p < 0.01)及KL-6(p = 0.02)与CT浸润灶的存在相关。
  • 浸润灶体积(p = 0.01)、肺部受累百分比(p = 0.01)及实变(p = 0.043)与后续出现症状相关。

临床应用与阅片要点

  • 对疫情环境下有暴露或旅行风险的无症状者,入院当日胸部CT可发现早于症状的浸润灶,阅片时需关注磨玻璃影和实变。
  • 结合体温、CRP及KL-6可辅助识别就诊时已有CT浸润灶的无症状感染者。
  • 浸润灶体积较大、肺部受累百分比较高及存在实变者,可能后续出现症状。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The early infection dynamics of patients with SARS-CoV-2 are not well understood. We aimed to investigate and characterize associations between clinical, laboratory, and imaging features of asymptomatic and pre-symptomatic patients with SARS-CoV-2.

METHODS: Seventy-four patients with RT-PCR-proven SARS-CoV-2 infection were asymptomatic at presentation. All were retrospectively identified from 825 patients with chest CT scans and positive RT-PCR following exposure or travel risks in outbreak settings in Japan and China. CTs were obtained for every patient within a day of admission and were reviewed for infiltrate subtypes and percent with assistance from a deep learning tool. Correlations of clinical, laboratory, and imaging features were analyzed and comparisons were performed using univariate and multivariate logistic regression.

RESULTS: Forty-eight of 74 (65%) initially asymptomatic patients had CT infiltrates that pre-dated symptom onset by 3.8 days. The most common CT infiltrates were ground glass opacities (45/48; 94%) and consolidation (22/48; 46%). Patient body temperature (p < 0.01), CRP (p < 0.01), and KL-6 (p = 0.02) were associated with the presence of CT infiltrates. Infiltrate volume (p = 0.01), percent lung involvement (p = 0.01), and consolidation (p = 0.043) were associated with subsequent development of symptoms.

CONCLUSIONS: COVID-19 CT infiltrates pre-dated symptoms in two-thirds of patients. Body temperature elevation and laboratory evaluations may identify asymptomatic patients with SARS-CoV-2 CT infiltrates at presentation, and the characteristics of CT infiltrates could help identify asymptomatic SARS-CoV-2 patients who subsequently develop symptoms. The role of chest CT in COVID-19 may be illuminated by a better understanding of CT infiltrates in patients with early disease or SARS-CoV-2 exposure.

KEY POINTS: • Forty-eight of 74 (65%) pre-selected asymptomatic patients with SARS-CoV-2 had abnormal chest CT findings. • CT infiltrates pre-dated symptom onset by 3.8 days (range 1-5). • KL-6, CRP, and elevated body temperature identified patients with CT infiltrates. Higher infiltrate volume, percent lung involvement, and pulmonary consolidation identified patients who developed symptoms.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Varble N, Blain M, Kassin M, et al. CT and clinical assessment in asymptomatic and pre-symptomatic patients with early SARS-CoV-2 in outbreak settings. Eur Radiol. 2020. PMID: 33146796. doi:10.1007/s00330-020-07401-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。